These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21712710)

  • 1. For the love of paradox: from neurobiology to pharmacology.
    Bond RA; Giles H
    Behav Pharmacol; 2011 Sep; 22(5-6):385-9. PubMed ID: 21712710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?
    Bond RA; Spina D; Parra S; Page CP
    Pharmacol Ther; 2007 Sep; 115(3):360-74. PubMed ID: 17681610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.
    Taira CA; Carranza A; Mayer M; Di Verniero C; Opezzo JA; Höcht C
    Curr Clin Pharmacol; 2008 Sep; 3(3):174-84. PubMed ID: 18781904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenoceptor inverse agonists in asthma.
    Dickey BF; Walker JK; Hanania NA; Bond RA
    Curr Opin Pharmacol; 2010 Jun; 10(3):254-9. PubMed ID: 20399707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Think the impossible: beta-blockers for treating asthma.
    Lipworth BJ; Williamson PA
    Clin Sci (Lond); 2009 Oct; 118(2):115-20. PubMed ID: 19807697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.
    Callaerts-Vegh Z; Evans KL; Dudekula N; Cuba D; Knoll BJ; Callaerts PF; Giles H; Shardonofsky FR; Bond RA
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4948-53. PubMed ID: 15069206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical pharmacology: turning our pharmacological models upside down.
    Page C
    Trends Pharmacol Sci; 2011 Apr; 32(4):197-200. PubMed ID: 21458081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology.
    Kaumann AJ; Molenaar P
    Pharmacol Ther; 2008 Jun; 118(3):303-36. PubMed ID: 18501968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-adrenoceptor blockers in patients with congestive heart failure.
    Panfilov V; Wahlqvist I; Olsson G
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):273-87. PubMed ID: 7662594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.
    Nguyen LP; Omoluabi O; Parra S; Frieske JM; Clement C; Ammar-Aouchiche Z; Ho SB; Ehre C; Kesimer M; Knoll BJ; Tuvim MJ; Dickey BF; Bond RA
    Am J Respir Cell Mol Biol; 2008 Mar; 38(3):256-62. PubMed ID: 18096872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenergic betareceptors and cardiac insufficiency].
    Weber S; Cabanes L; Guérin F
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1957-61. PubMed ID: 1980187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving concepts concerning cardiac β-adrenoceptor function in heart failure.
    James B; Desmond F
    Curr Pharm Des; 2010; 16(37):4148-58. PubMed ID: 21247393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
    McDevitt DG
    Drugs; 1983 Apr; 25(4):331-8. PubMed ID: 6133735
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoring function in failing hearts: the effects of beta blockers.
    Eichhorn EJ
    Am J Med; 1998 Feb; 104(2):163-9. PubMed ID: 9528736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of congestive heart failure with beta-adrenergic blockers: a brief review of literature.
    Lee YC
    Md Med J; 1998; 47(2):67-71. PubMed ID: 9524413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.